AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 231 min read$HNGE

Pursley James sold $3.1M of HNGE

Pursley James (President) sold 33,000 shares of Hinge Health, Inc. (HNGE) at an average of $94.14 ($93.37–$95.10, $3.11M total) across 3 trades on 2026-09-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Pursley James
Published Sep 23, 2026, 9:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 9:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$HNGE
Bearish
medium confidence
Mentioned
$HNGE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGEBearishLow
01

Why it matters

The sale reduces insider ownership but is modest; market reaction likely muted.

02

Market read

Primary relevance is to HNGE shareholders; limited spillover to sector.

03

What to watch

Sale executed via pre-arranged 10b5-1 plan, reducing informational value of the transaction.

Relevance 5/10Novelty 7/10Timing: after-hours filing on 2026-09-23

Background

Form 4 filings disclose insider transactions; investors monitor them for potential signals.

Company-level read

Ticker impact

$HNGEBearishMedium confidence
Context

President James Pursley sold 33,000 shares for $3.1M via a 10b5-1 plan, reducing his stake to 666,909 shares.

Expected impact

Modest short-term dip, 1-2% decline expected.

Evidence & confidence

Sale size is modest relative to market cap but involves a top executive; market may interpret as a negative signal.

Market effects

Sector

Minimal impact on digital health sector; no broader industry signal.

Regional

Limited to US market where HNGE trades.

Global

Low global relevance.

Counterpoint

What could challenge this read

Insider may be diversifying portfolio; sale does not necessarily indicate negative fundamentals.

Key entities

  • Company
    Hinge Health, Inc.

    Digital health platform listed as HNGE.

  • Executive
    Pursley James

    President of Hinge Health.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

HNGE insider trading history →

Related articles

AUG 28
$HNGEHighAI 8/10

Could Hinge Health (HNGE) Stock Win as Digital Healthcare Expands Beyond MSK Care?

Hinge Health (NYSE:HNGE) raised its 2026 revenue guidance to $856M-$860M, up from $822.16M consensus. Q2 2026 revenue grew 53% YoY to $213M, with non-GAAP operating income doubling to $62M. The company announced a $105M acquisition of Cylinder Health and expanded its share repurchase program by $300M. Analysts RBC and Truist raised price targets to $110 and $112, respectively, citing strong growth and platform expansion.

finance.yahoo.com3 min
AUG 19
$HNGEMedAI 8/10

HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?

Hinge Health (HNGE) stock has risen 90% YTD, outperforming industry and S&P 500. Q2 revenue grew 53% YoY to $213M, with 2026 guidance raised to $856-$860M. AI and automation improved margins, while new care programs expand market reach. Analysts project 2026 EPS of $2.50 and 2027 EPS of $3.29. Growth is driven by member yield, AI efficiency, and new care offerings, but execution risks remain.

zacks.com3 min
AUG 15
$HNGEMed

Jim Cramer says one stock hitting new highs is still a screaming buy

Jim Cramer reiterated a triple buy call on Hinge Health (HNGE) on “Mad Money” Aug. 11. The stock hit a new all-time high of $93.13 on Aug. 10 and is up about 85.83% YTD, per Yahoo Finance. Hinge reported Q2 2026 revenue of $213 million (+53% YoY), free cash flow of $99.6 million, and raised FY guidance to $856-$860 million. It also agreed to a $105 million cash acquisition (Cylinder Health) to expand into GI care.

yahoo.com6 min
AUG 12
$HNGEMed

Hinge Health (HNGE) Just Bought Its Way Into A New Market, So Now What?

Hinge Health (NASDAQ:HNGE) reported Q2 revenue of $213 million, up 53% year over year, above guidance of $200 million to $202 million. Gross margin rose to 87% and operating income to $62 million. The company said it used $105 million cash to acquire Cylinder Health for gastrointestinal care, while also expanding its migraine offering. It raised FY revenue guidance to $856 million to $860 million and authorized a $300 million buyback.

insidermonkey.com7 min
AUG 5
$HNGEHighAI 9/10

Why is Hinge Health stock surging today?

Hinge Health (HNGE) shares rose 11.6% after the company reported Q2 2026 revenue of $212.8M (+53% YoY) and non-GAAP diluted EPS of $0.59 vs $0.13 consensus. Free cash flow exceeded $100M. Hinge raised FY2026 revenue guidance to $818M-$824M and Q3 guidance to $223M-$225M, and agreed to buy Cylinder Health for $105M cash. Analysts lifted price targets.

investing.com4 min